Association between PGC-1α gene variations and physical performance in non-athletic boys

authors:

avatar Fatemeh Rostam Zadeh Shuti , avatar Farzad Zehsaz , *

Koomesh: Vol.22, issue 3; 492-496
published online: September 08, 2019
article type: Research Article
received: May 02, 2018
accepted: September 08, 2019

how to cite: Rostam Zadeh Shuti F, Zehsaz F. Association between PGC-1α gene variations and physical performance in non-athletic boys. koomesh. 2020;22(3):e153206. 

Abstract

Introduction: PGC-1α gene plays an important role in regulating cellular energy metabolism and stimulating the increased cell mitochondrial mass. Understanding the status of this gene polymorphism in non-athletic male adolescents may be helpful in choosing and identifying the sport talented male adolescents. The purpose of the present study was to investigate possible association between PGC-1α gene polymorphisms and physical performance in non-athletic male adolescents of Urmia (Iran).  Materials and Methods: The research was quasi-experimental in a field manner in which 124 non-athletic male adolescent of Urmia (age mean: 11.14±0.69 years old weight mean: 41.09±10.97 kg height: 143.18±7.78 cm and BMI: 19.85±4.16) participated in the saliva tests to determine PGC-1α polymorphism and in the field tests of Andersen, standing broad jump, Aalakov jump, counter-movement jump and 20-m sprint. Gene polymorphisms was performed were determined using the PCR-RFLP method. Results: Among the three different types of exercise performance (endurance, power, speed), PGC-1α polymorphism only had a significant effect on the endurance performance of the subjects and remarkably, the group with the dominant Gly/Gly genotype had a better endurance performance. Conclusion: The results of this study indicated that PGC-1α polymorphism of non-athlete adolescents was a determinative factor in their endurance performance, but not a determinative one in their speed and power performance.  

References

  • 1.

    Roth SM. Critical overview of applications of genetic testing in sport talent identification. Recent Pat DNA Gene Seq 2012; 6: 247-255.

  • 2.

    Ordovas JM. Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention. Am J Clin Nutr 2009; 89: 1509s-1517s.

  • 3.

    Lin J, Handschin C, Spiegelman BM. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005; 1: 361-370.

  • 4.

    Muller YL, Bogardus C, Pedersen O, Baier L. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes 2003; 52: 895-898.

  • 5.

    Lucia A, Gomez-Gallego F, Barroso I et al. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J Appl Physiol (1985) 2005; 99: 344-348.

  • 6.

    Gineviciene V, Jakaitiene A, Aksenov MO, Aksenova AV, Druzhevskaya AM, Astratenkova IV, et al. Association analysis of ACE, ACTN3 and PPARGC1A gene polymorphisms in two cohorts of European strength and power athletes. Biol Sport 2016; 33: 199-206.

  • 7.

    Tzavara C, Tzonou A, Zervas I, Ravens-Sieberer U, Dimitrakaki C, Tountas Y. Reliability and validity of the KIDSCREEN-52 health-related quality of life questionnaire in a Greek adolescent population. Ann Gen Psychiatry 2012; 11:1-7.

  • 8.

    Hagstromer M, Oja P, Sjostrom M. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr 2006; 9: 755-762.

  • 9.

    Garner DM, Garfinkel PE. The Eating Attitudes Test: an index of the symptoms of anorexia nervosa. Psychol Med 1979; 9: 273-279.

  • 10.

    Andersen LB, Andersen TE, Andersen E, Anderssen SA. An intermittent running test to estimate maximal oxygen uptake: the Andersen test. J Sport Med Phys Fit 2008; 48: 434-437.

  • 11.

    David T Gray, Julien S Baker, Buchan DS. Weight Status, Physical Activity and the Associations with Health Related Physical Fitness in Nine to Twelve Year Old Scottish Children. J Sports Med Doping Stud 2013; 3: 1-5.

  • 12.

    Santiago C, Rodriguez-Romo G, Gomez-Gallego F, Gonzlez-Freire M, Yvert T, Verde Z, et al. Is there an association between ACTN3 R577X polymorphism and muscle power phenotypes in young, non-athletic adults? Scand J Med Sci Spor 2010; 20: 771-778.

  • 13.

    Bosco C. Strength Assessment With the Boscos Test. Barcelona, Spain: Paidotribo; 1994.

  • 14.

    Contr V, Schiera G, Abbruzzo A, Bianco A, Amato A, Sacco A, et al. An innovative way to highlight the power of each polymorphism on elite athletes phenotype expression. Eur J Transl Myol 2018; 28: 7186.

  • 15.

    Zehsaz F, Safabakhsh AH, Farhangi N, Keynezhad N, Monfaredan A, Ghahramani M. Do ACE and CKMM gene variations have potent effects on physical performance in inactive male adolescents? Mol Biol Rep 2019; 46: 1835-1843.

  • 16.

    Bayindir B, Kolayi E. Comparision of Strenght Speed and Endurance in 11-13 Age Boys and Girls. Procedia Soc Behav Sci 2015; 174: 3292-3298.

  • 17.

    Maciejewska A, Sawczuk M, Cieszczyk P, Mozhayskaya IA, Ahmetov II. The PPARGC1A gene Gly482Ser in Polish and Russian athletes. J Sports Sci 2012; 30: 101-113.

  • 18.

    Zehsaz F, Abbasi Soltani H, Hazrati R, Farhangi N, Monfaredan A, Ghahramani M. Association between the PPARa and PPARGCA gene variations and physical performance in non-trained male adolescents. Mol Biol Rep 2018; 45: 2545-2553. ##.